Suraksha Diagnostic IPO GMP 2024: Dates, Price & Details
As we can all see, diagnostic centres and specialised clinics occupy an unchallengeable position in the world that is changing so rapidly in the sphere of healthcare. Such is the case with Suraksha Clinic and Diagnostic which provides total health care services to the clients. Offering the basic health check-ups to diagnostic services, Suraksha leverages technology to cater to a wide raft of healthcare services while remaining very patient focused.
With its beginnings in 1992 as Suraksha Diagnostic Private Ltd. at Kolkata, Suraksha Clinic and Diagnostic Limited has indeed grown to become one of Eastern India’s leading health care service providers. There’s a directory of services provided by the firm including pathology, radiology and medical consultation services to suit every patient.
Suraksha Diagnostic Overview and Vision
Suraksha Clinic and Diagnostic currently have a large multicentric network in West Bengal, Bihar, Assam and Meghalaya. By June 30, 2024, the company had established the central reference laboratory, 8 satellite laboratories, 49 diagnostic centers and 166 sample collection points. This widespread has sent a clear signal to the public that aims at providing quality and affordable health services.
The goal of Suraksha Clinic and Diagnostic is to offer convenient, inexpensive, and accurate diagnostic and clinical care. The organisation imagines a healthier society through facilitating the provision of accurate and timely solutions to all patients.
Suraksha Clinic and diagnostic services and specialties:
Imaging: The types of the medical imaging technologies include Digital X-ray, Ultrasound (USG), Computerised Tomography Scan (CT Scan), Magnetic Resonance Imaging (MRI), Dual Energy X-ray Absorptiometry(DEXA) Scan and Mammography.
Cardiology: ECG, Echocardiogram, TMT, Holter Monitoring, Color & Peripheral Doppler, PFT.
Neurology: These tests include Electroencephalogram (EEG), electromyography (EMG) and nerve conduction velocity (NCV) test.
Gastroenterology: Upper and Lower Endoscopy/Esophagoscopy, Sigmoidoscopy, Proctoscopy, Colonoscopy and Proctosigmoidoscopy.
Pathology: General, gross & elective, light, Electron Microscopy, fluorescent microscopy & immunofluorescence, immunohistochemistry, FISH & visit & flow cytometry, LC-MS/MS & NGSeq & fast & versatile.
This diversified specialization makes Suraksha Clinic and Diagnostic a one stop solution for most diagnostic services within the area.
Key Technology and Infrastructure
Automation-enabled smart lab
APTIO automation enables direct front-loading of the samples that may be needed urgently, or low turnaround samples to meet the most demanding turnaround time. The 26 meters long AI integrated automatic track offers all required pre and post analytical processing systems and the latest analytical technologies in haematology, immunoassay and chemistry. This feature utilizes the technology of sample loading and handling including sorting of tubes, offloading conveniently saving the time of the laboratory staff from mere tasking activities. The afore-mentioned track-based automation solution which enthusiasm having interfaces of the different clinical disciplines, the testing methodologies and the analysers.
APTIO automation also helps staff to aliquot different types of samples (EDTA whole blood, serum, urine), one from the other. The track also avoids pre analytical errors common with test request and tube type; highlights the presence of problem samples like a misread bar code or missing work order to the operator. It has implemented connections to analysers, allowing quicker routine and speciality testing.
Integration of IT and quality control mechanisms.
Suraksha Diagnostic hired very competent and qualified persons under the categories of ‘Laboratory Operations’ and ‘Central Quality cell’ headed by Laboratory Director who supervises all the laboratory activity for the day, preparing standard operating procedures, (SOPs), quality policies, implementation of quality management system (QMS), internal audits of the lab activities, accreditation of the laboratory, recruitment of qualified lab doctors and technicians, selection of the equipment and assuring It has its own IT Cell that maintains efficient functioning of the information systems during operations, server administration, networking / connectivity 24/7, equipment and software maintenance and the automation process, data protection and retrieval in addition to records management.
Logistical Infrastructure and Management
However, the lab still has a robust QA/QC mechanism and also a good logistics chain. One of the value-added segments which is directly impacting on pre-analytical quality of service in lab service are sample transportation and to deliver the best performance in this segment Suraksha is committed. The logistics of the samples are provided by several different agencies to whom the service is subcontracted because those agencies specialize in the transport of biological material. Logistic boys transport the sample from all centres to the laboratory where the actual sample test is conducted. The coordinators of the agency with focus on the supervisor / logistic officer always deal with the courier boys and dispatch officers of the centres. The supervisors also report to the Sample Receiving In charge of the laboratory.
Financial Performance of Suraksha Clinic and diagnostic
As on 31 st March, 2024, Suraksha Clinic and Diagnostic annual gross of ₹ 219 crore was achieved than the previous FY of ₹ 190 crore. The profit after tax (PAT) was up with ₹23 crore compared to ₹6.51 crore in the previous year.
The revenue growth of the company has been also explained by the increasing service range, advanced technology, and patients’ needs focus. The company is poised for a listing of its shares in the next fiscal year, which is expected to strengthen its balance sheet and effect expansion initiatives.
Suraksha Diagnostic IPO GMP , Dates and Allotment
Using Public Issue, Suraksha Diagnostic IPO share price have planned to mobilise ₹846.25 crore through an Initial Public Offering. The IPO is proposed to open on November 29, 2024 and to close on December 3, 2024. The price band for the offer has been fixed between ₹420/- and ₹441/- per equity share of face value ₹2 each.
The IPO is entirely an OFS, which means the IPO comprises up to 19,189,330 equity shares by the existing shareholders such as promoters and the promoter group entities. The proceeds from the offer will be paid directly to the selling shareholders of ON semiconductor.
Out of the total issue, the company is offering 50% for Qualified Institutional Buyers (QIBs), 35% for the retail segment and 15% of the non-institutional segment. The number of shares offered to the public is 34 equity shares and thereafter the lots are available in multiple of 34 shares only.
Suraksha Diagnostic IPO Details
IPO Date | November 29, 2024 to December 3, 2024 |
Listing Date | December 6, Friday |
Face Value | ₹2 per share |
Price Band | ₹420 to ₹441 per share |
Lot Size | 34 Shares |
Total Issue Size | 19,189,330 shares (aggregating up to ₹846.25 Cr) |
Offer for Sale | 19,189,330 shares of ₹2 (aggregating up to ₹846.25 Cr) |
Issue Type | Book Built Issue IPO |
Listing At | BSE, NSE |
Shareholding pre issue | 52,080,758 |
Suraksha Diagnostic IPO Lot Allotment
Application | Lots | Shares | Amount |
Retail (Min) | 1 | 34.00 | ₹14,994 |
Retail (Max) | 13 | 442.00 | ₹194,922 |
S-HNI (Min) | 14 | 476 | ₹209,916 |
S-HNI (Max) | 66 | 2,244.00 | ₹989,604 |
B-HNI (Min) | 67 | 2,278.00 | ₹1,004,598 |
Suraksha Clinic and Diagnostic IPO Dates and Timeline
IPO Open Date | Friday, November 29, 2024 |
IPO Close Date | Tuesday, December 3, 2024 |
Basis of Allotment | Wednesday, December 4, 2024 |
Initiation of Refunds | Thursday, December 5, 2024 |
Credit of Shares to Demat | Thursday, December 5, 2024 |
Listing Date | Friday, December 6, 2024 |
Cut-off time for UPI mandate confirmation | 5 PM on December 3, 2024 |
Suraksha Diagnostic IPO GMP
Suraksha Diagnostic IPO GMP is ₹0, last updated Nov 27th 2024 02:00 PM. With the Suraksha Diagnostic IPO share price band of 441.00, Suraksha Clinic and Diagnostic IPO’s estimated listing price is ₹441 (cap price + today’s GMP).The expected percentage gain/loss per share is 0.00%.
The way forward of Suraksha Diagnostic IPO
The company has planned to develop 10-15 new centres in the next few years and four to six satellite labs at other places in India. It is therefore expected that the investment cost will range for Rs 70 – 100 crores. The only thing that will be a worry when they are aiming at extending the services they offer is having set high standards of the lab centres, and how to maintain them throughout. With the volumes, the diagnostic chain will have to find a way to do more at a cheaper price while still maintaining quality of services for the business to continue running in the future. The question is whether this diagnostic chain can afford to automate all its labs or if it will stick to the centralized lab model and increase the number of collection centres.
Conclusion
Suraksha Clinic and Diagnostic Limited is set up in Eastern India providing detailed diagnostic services through its network arm. This contributed mainly to the growth of the firm due to its commitment towards assimilation of technology, quality services and patient… The IPO planned for the near future represents an important step in its evolution – it offers a chance to become its stakeholder.
Given that the world is experiencing inestimable energy crises, the attempts of Rajesh Power with regard to offering environmentally friendly, efficient, and cheap energy will always be significant. However, this should light up homes and guide the company to a future where it lives by that true value sustainability.
Also Read : Top EV Stocks in India : 2025
FAQ'S
What is the suraksha diagnostic ipo gmp (Grey Market Premium) ?
Suraksha Clinic and Diagnostic IPO last GMP is ₹0, last updated Nov 27th 2024 02:00 PM. With the Suraksha Diagnostic IPO share price band of 441.00, Suraksha Clinic and Diagnostic IPO’s estimated listing price is ₹441 (cap price + today’s GMP).The expected percentage gain/loss per share is 0.00%.
When is the Suraksha Diagnostic IPO expected to open ?
The exact opening and closing dates for the The IPO is proposed to open on November 29, 2024 and to close on December 3, 2024.
What is the business model of Suraksha Diagnostic ?
Suraksha Diagnostic operates a chain of diagnostic and healthcare centers across India, offering pathology and imaging services. Its focus is on expanding its network and providing affordable diagnostic solutions.
How can I apply for the Suraksha Diagnostic IPO ?
You can apply for the IPO through your Demat account by using the ASBA (Applications Supported by Blocked Amount) feature on your bank or broker’s platform. Ensure your account is updated with the required funds and KYC compliance.
Is investing in Suraksha Diagnostic IPO a good decision ?
Investment decisions should be based on individual financial goals and risk tolerance. Analyzing the company’s financial performance, market position, and the healthcare sector’s growth potential can help in making an informed choice. Consulting with financial advisors is also recommended.
